USA DNA TESTTM

MENTAL HEALTH
PHARMACOGENOMIC TESTING FOR
MENTAL HEALTH
Neuroactive drugs (NAD's) such as antidepressants, antipsychotics, and anxiolytics are important treatments for mental health. However, determining efficacy and appropriate dosage can be difficult, resulting in the following potentially negative outcomes:
  • ​​Approximately 50% of all patients do not respond well enough to first line medication - requiring a time-consuming and exhaustive trial and error process to access the optimal drug.
  • Treatment benefits can also take weeks to achieve, prolonging the trial and error process even further.
  • Patients may encounter adverse side effects with no benefits or face negative reactions when NAD's interact with other prescription medication.  
BENEFITS 
  • ​​Pharmacogenetic testing for NAD's can help physicians implement the appropriate drug and dosage to minimize the risk of adverse side effects or toxic reactions and ensure proper response
  • Determining the optimal drug early on can avoid an exhaustive, time-consuming process of treatment trial and error that may have negative effects or no benefit at all.
  • Testing information can be used as an adjunct to other tools for clearer guidance in selecting among various therapeutic choices for each patient.